1151564-03-2 Usage
Uses
Used in Pharmaceutical Industry:
2-(2-CHLORO-3-METHOXYPHENYL)-4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLANE is used as a reagent for the Suzuki coupling reaction in the pharmaceutical industry. It facilitates the synthesis of complex organic molecules with selective and efficient formation of carbon-carbon bonds, which is crucial for the development of new drugs and pharmaceutical compounds.
Used in Agrochemical Industry:
In the agrochemical industry, 2-(2-CHLORO-3-METHOXYPHENYL)-4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLANE serves as a key reagent for the synthesis of various agrochemical compounds. The Suzuki coupling reaction, facilitated by this boronic ester, allows for the creation of complex organic molecules that can be used in the development of pesticides, herbicides, and other agrochemical products.
Used in Material Science:
2-(2-CHLORO-3-METHOXYPHENYL)-4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLANE is utilized as a reagent in the material science field for the synthesis of advanced organic materials. The Suzuki coupling reaction, made possible by 2-(2-CHLORO-3-METHOXYPHENYL)-4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLANE, enables the formation of complex molecular structures that can be used in the development of new materials with unique properties, such as high-performance polymers, conductive materials, and other specialized materials for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1151564-03-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,5,1,5,6 and 4 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1151564-03:
(9*1)+(8*1)+(7*5)+(6*1)+(5*5)+(4*6)+(3*4)+(2*0)+(1*3)=122
122 % 10 = 2
So 1151564-03-2 is a valid CAS Registry Number.
1151564-03-2Relevant academic research and scientific papers
PROCESSES FOR THE PREPARATION OF URACIL DERIVATIVES
-
Page/Page column 23, (2009/06/27)
The present invention relates to processes and intermediates for preparing Gonadotropin-Releasing Hormone (GnRH) receptor antagonists of structure (VI); and stereoisomers and pharmaceutically acceptable salts thereof.
